Date Effective: May 24, 2023
Below are clinician guidelines and position statements for using FemmenessencePRO in your clinical practice. Be sure to check back often for updates.
FemmenessencePRO™ and Hashimoto’s Thyroiditis-Clinician Guidelines
Patients with a current diagnosis or a history of Hormone Sensitive Cancers Seeking Relief of Menopausal Symptoms – Position Statement
FemmenessencePRO™ Dosing Guidelines for Clinicians
Below are assessments and clinician guidelines for using HerbatoninPRO in your clinical practice. Be sure to check back often for updates.